Student, 22, in early 'menopause' due to injections to alleviate endometriosis symptoms
Katy Johnson, 22, from Aberdeen, was diagnosed with stage four endometriosis in January. She now has injections that will stop her ovulating for a year to give her ovaries 'a break'. (Source: the Mail online | Health)
Source: the Mail online | Health - June 19, 2018 Category: Consumer Health News Source Type: news

Finding genes controlling ovarian reserve could hold key to better female fertility care
(Jackson Laboratory) Jackson Laboratory Assistant Professor Ewelina Bolcun-Filas, Ph.D., is looking at how multiple genetic factors regulating oocyte development determine the differences in each woman's ovarian reserve. Bolcun-Filas has received a five-year grant totaling $2,165,475 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to investigate these genetic factors, using special, genetically diverse mouse populations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Bevacizumab Rechallenge Benefit in Recurrent Ovarian Cancer?
New data suggest adding bevacizumab to chemotherapy may prolong PFS in patients with recurrent ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 19, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Fertility Struggles More Open – and Shared on Social Media
By Michelle Catenacci, M.DCHICAGO, Jun 18 2018 (IPS)Fertility health is an incredibly personal – and often vulnerable – topic. Fertility, infertility, and fertility preservation have gained increased public interest over the past few years. Infertility is formally defined as the inability to achieve pregnancy after one year of unprotected intercourse. The Centers for Disease Control and Prevention (CDC) reports that approximately 12% of women aged 15 to 44 in the United States have difficulty getting pregnant or carrying a pregnancy to term. Even though a significant proportion of the population suffers from th...
Source: IPS Inter Press Service - Health - June 18, 2018 Category: International Medicine & Public Health Authors: Michelle Catenacci Tags: Aid Education Featured Gender Global Headlines Health Population Poverty & SDGs TerraViva United Nations Source Type: news

New study suggests ovarian hormone may make drug withdrawal symptoms worse for women
(Dickinson College) Researchers found that a form of the estrogen hormone can contribute to drug relapse in females by worsening withdrawal symptoms. The study looked at the interaction of the female sex hormone estradiol and methamphetamine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 18, 2018 Category: International Medicine & Public Health Source Type: news

HEALTH NOTES: Find out your risk of cancer  
Find out how women can discover their risk of ovarian cancer and the potential reason Radio 2 DJ Jo Whiley is suffering fr om agonising shoulder pain. (Source: the Mail online | Health)
Source: the Mail online | Health - June 17, 2018 Category: Consumer Health News Source Type: news

This Jacksonville company's stock is surging as the market sees there's "no competitor"
TapImmune Inc. stock has blossomed in the month since it announced it will merge with a company producing similar cancer-fighting treatments, begin a strategic alliance with Baylor College of Medicine and move to Houston. The stock has more than tripled since the announcement and rose more than 18 percent Friday. TapImmune (Nasdaq: TPIV) develops cancer-fighting immunotherapies that target breast and ovarian cancers. It is merging with Marker Therapeutics Inc., which develops similar therapies,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 15, 2018 Category: American Health Authors: Will Robinson Source Type: news

Medical News Today: What are the first symptoms of ovarian cancer?
Ovarian cancer is a condition that can be detected and treated, the key is knowing the symptoms. The earlier these are detected and diagnosed, the better the outcome is likely to be. Symptoms include bloating, pelvic pain, and painful sex. Learn more about early signs of ovarian cancer, and when to see a doctor, here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 15, 2018 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Sex-change mice research could help humans, say scientists
Removal of enhancer 13 DNA strands caused males to grow ovaries and female genitalia, helping research on human sexual development disordersScientists have turned male mice into females by snipping out strands of their DNA in work that could shed light on sexual development disorders which arise in humans.The male mice grew ovaries and female genitalia instead of the more conventional male anatomy after researchers removed small chunks of DNA from the animals ’ genetic code.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 15, 2018 Category: Science Authors: Ian Sample Science editor Tags: Genetics Science Biology Gender Medical research Source Type: news

FDA approves Roche ’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery
Roche today announced that the US Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection. (Source: Roche Media News)
Source: Roche Media News - June 13, 2018 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery
Roche today announced that the US Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection. (Source: Roche Investor Update)
Source: Roche Investor Update - June 13, 2018 Category: Pharmaceuticals Source Type: news

CTCs as a Predictive Biomarker in Suspected Ovarian Cancer CTCs as a Predictive Biomarker in Suspected Ovarian Cancer
Might circulating tumor cells be useful as a diagnostic biomarker in women with complex pelvic masses?Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

MD Anderson, Houston Methodist scientists detect new ovarian cancer target
(University of Texas M. D. Anderson Cancer Center) Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves Genentech ’s Avastin (bevacizumab) Plus Chemotherapy as a Treatment for Women With Advanced Ovarian Cancer Following Initial Surgery
South San Francisco, CA -- June 13, 2018 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin ® (bevacizumab) in combination with chemotherapy... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 13, 2018 Category: Drugs & Pharmacology Source Type: news

Online tool can calculate women's genetic risk of ovarian cancer
An online tool developed by the charity Ovarian Cancer Action can work out a woman's genetic risk of getting the disease by considering her family history of genetic mutation and cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2018 Category: Consumer Health News Source Type: news

At 24, I’ve had a double mastectomy to beat the cancer curse on family
A WOMAN aged just 24 is one of the youngest in Britain to have a double mastectomy after seeing her mother and eight other relatives battle cancer. Esther Taylor has a gene mutation meaning she is at “high risk” of developing breast and ovarian cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 12, 2018 Category: Consumer Health News Source Type: news

Woman is one of the youngest in the UK to have a double mastectomy
Esther Taylor,  from Preston, Lancashire, has an unidentified mutation that puts her at high risk of breast and ovarian cancer. She underwent the grueling nine-hour operation last March. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2018 Category: Consumer Health News Source Type: news

Woman, 24, is one of the youngest in the UK to have a double mastectomy
Esther Taylor,  from Preston, Lancashire, has an unidentified mutation that puts her at high risk of breast and ovarian cancer. She underwent the grueling nine-hour operation last March. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2018 Category: Consumer Health News Source Type: news

In Missouri, J & J Faces Biggest Trial Yet Alleging Talc Caused Cancer In Missouri, J & J Faces Biggest Trial Yet Alleging Talc Caused Cancer
A lawsuit by 22 ovarian cancer patients against Johnson& Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company has faced over allegations its talc-based products contain cancer-causing asbestos.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Johnson & Johnson defends talc products in latest court proceeding
Johnson& Johnson is being sued by a group of 22 ovarian cancer patients. The New Brunswick, New Jersey-based company (NYS: JNJ) faces charges that its talc-based products contain asbestos. The trial was brought forward by women who contend that J&J-branded baby powder contained the cancer-causing substance dating back at least to the 1970s. They also contend that J&J knew its talc was contaminated but failed to warn consumers about the risks. J&J has denied the assertions and maintains that its … (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 8, 2018 Category: American Health Authors: Anthony Noto Source Type: news

Obese women with PCOS can improve their health by simply soaking in a hot tub
(Natural News) Polycystic ovary syndrome (PCOS) is one of the most common hormonal problems women face today. It is said that at least five to 10 percent of women of childbearing age are diagnosed with it. For years patients have been treating the illness by taking hormonal pills, but researchers recently discovered a new remedy.... (Source: NaturalNews.com)
Source: NaturalNews.com - June 7, 2018 Category: Consumer Health News Source Type: news

Johnson & Johnson defends talc products in latest court proceeding
Johnson& Johnson is being sued by a group of 22 ovarian cancer patients. The New Brunswick, New Jersey-based company (NYS: JNJ) faces charges that its talc-based products contain asbestos. The trial was brought forward by women who contend that J&J-branded baby powder contained the cancer-causing substance dating back at least to the 1970s. They also contend that J&J knew its talc was contaminated but failed to warn consumers about the risks. J&J has denied the assertions and maintains that its … (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 7, 2018 Category: Health Management Authors: Anthony Noto Source Type: news

Mother-of-one lost her ovaries, uterus and TOES due to rare IUD complication
WARNING: GRAPHIC IMAGES Tanai Smith, 25, from Baltimore, Maryland, suffered a rare complication after her IUD slipped to her stomach and she lost her ovaries, uterus and toes. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2018 Category: Consumer Health News Source Type: news

Secondary Surgery Fails to Improve Outcomes in Recurrent Ovarian Cancer
Dave LevitanJun 7, 2018Secondary cytoreductive surgery was not associated with improvement in either OS or PFS in patients with platinum-sensitive recurrent ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 7, 2018 Category: Cancer & Oncology Authors: A Source Type: news

In Missouri, J & J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) - A lawsuit by 22 ovarian cancer patients against Johnson& Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company has faced over allegations its talc-based products contain cancer-causing asbestos. (Source: Reuters: Health)
Source: Reuters: Health - June 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Olaparib Plus Vistusertib Promising in Early Trial of Endometrial, Other Cancers
Dave LevitanJun 6, 2018The combination of the PARP inhibitor olaparib with the mTORC1/2 inhibitor vistusertib had promising activity across endometrial, ovarian, and triple-negative breast cancers. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Noninferiority of Neoadjuvant Chemo Cannot Be Confirmed in Ovarian Cancer Trial
Dave LevitanJun 6, 2018The noninferiority of neoadjuvant chemotherapy vs upfront surgery could not be confirmed with regard to overall survival in patients with ovarian, tubal, and peritoneal cancers. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news

PFS Rises in Ovarian Ca with Repeat Bevacizumab
(MedPage Today) -- Magnitude of benefit similar to first-line therapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 6, 2018 Category: Hematology Source Type: news

Medical News Today: Why does perimenopause cause ovary pain?
Perimenopause is the time when the body is preparing for menopause, and it can last several years. During this time, hormones levels fluctuate. This can cause irregular menstruation that may be more painful than usual. Read on to learn what causes perimenopause ovary pain, in particular, and how to treat the symptoms. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 5, 2018 Category: Consumer Health News Tags: Menopause Source Type: news

ASCO: Ovarian Suppression & #43; Tamoxifen Ups Breast CA Survival
TUESDAY, June 5, 2018 -- The addition of ovarian suppression to tamoxifen is associated with increased survival versus tamoxifen alone among premenopausal women with breast cancer, according to a study published online June 4 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 5, 2018 Category: Pharmaceuticals Source Type: news

Non-Chemo Combo Active in Ovarian Cancer
(MedPage Today) -- 25% objective response among patients with refractory disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 4, 2018 Category: Hematology Source Type: news

Ovarian Cancer vs Ovarian Cysts Symptoms and Signs
Ovarian Cancer vs. Ovarian Cysts Symptoms and Signs (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2018 Category: General Medicine Source Type: news

ASCO & NEJM: AI plus ovarian suppression yields benefit in high-risk younger breast cancer patients
(Dana-Farber Cancer Institute) Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant recurrence at eight years, according to a new clinical trial analysis reported at the annual meeting of the American Society of Clinical Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

Does stabilizing female hormones help lower suicide risk?
(University of Illinois at Chicago) A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

NHS cancer patients 'failing to be correctly monitored'
Concerns expressed that opportunities to save lives may be missedCancer patients in the UK may not receive enough follow-up after a diagnosis, a new study by researchers in Chicago suggests.The study, presented at the annual American Society of Clinical Oncology in Chicago, suggests five years of monitoring is insufficient for some cancers and too long for others. The research suggests some NHS patients may receive too few years of follow-up care.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 1, 2018 Category: Science Authors: Jessica Glenza in Chicago Tags: Cancer Cancer research Breast cancer Bowel cancer Cervical cancer Lung cancer Ovarian cancer Pancreas cancer Prostate cancer Health Medical research Science Society UK news Source Type: news

‘ Holy Grail ’ Blood Test May Detect Cancer Before Tumors Form
CLEVELAND, OH (CBS Local) – A new type of blood screening is being called the “holy grail of cancer research” by scientists who say the test can detect the disease before tumors even form in the body. The Details: A new blood test is successfully finding cancer before tumors form A liquid biopsy tests human DNA for genetic mutations linked to cancer The tests proved capable of detecting several hard-to-treat forms of the disease “This is potentially the holy grail of cancer research, to find cancers that are currently hard to cure at an earlier stage when they are easier to cure,” lead ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 1, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Blood Test Cancer Local TV talkers Source Type: news

Drug that halts spread of ovarian cancer now available through NHS
Drug rationing chiefs last night gave the green light for the daily pill niraparib to be prescribed to thousands of women with incurable ovarian cancer, in what charities hailed as a 'major breakthrough' (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2018 Category: Consumer Health News Source Type: news

Drug that halts spread of ovarian cancer is now available to thousands of women through NHS
Drug rationing chiefs last night gave the green light for the daily pill niraparib to be prescribed to thousands of women with incurable ovarian cancer, in what charities hailed as a 'major breakthrough' (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2018 Category: Consumer Health News Source Type: news

'Holy grail of cancer research': doctors positive about early detection blood test
Blood tests called liquid biopsies show signs of finding 10 different types of cancer at an early stageA blood test for 10 different types of cancers could one day help doctors screen for the disease before patients show symptoms, researchers at the world ’s largest gathering of oncologists have said.The test, called aliquid biopsy, screens for cancer by detecting tiny bits of DNA released by cancer cells into blood. The test had particularly good results for ovarian and pancreatic cancers, though the number of cancers detected was small.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 1, 2018 Category: Science Authors: Jessica Glenza in New York Tags: Cancer Medical research Health Science Society World news Bowel cancer Cancer research Lung cancer Ovarian cancer Prostate cancer Source Type: news

Blood test can detect TEN types of cancer before someone becomes ill
Scientists from the Cleveland Clinic in Ohio have found a simple blood test that can pick up early signs of 10 different types of cancer, including breast, ovarian, bowel and lung cancer (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2018 Category: Consumer Health News Source Type: news

Ovarian cancer - ‘game changing’ new drug puts patient’s tumour into remission
Ovarian cancer symptoms include stomach bloating, passing more urine than normal, and having pain during sex. A new “game-changing” treatment for tumours has been revealed today, and one patient’s cancer has been put into remission after taking the ‘niraparib’ tablets. (Source: Daily Express - Health)
Source: Daily Express - Health - May 31, 2018 Category: Consumer Health News Source Type: news

Despite risk of breast cancer, few men undergo genetic tests, study finds
Cancer is one of the leading causes of death among Americans. At least 10 percent of cancers are caused by inherited mutations in genes such as BRCA1 and BRCA2. Parents with the cancer gene mutation have a 50 percent chance of passing it on to a son or daughter. It ’s well-known that women with BRCA are at a very high risk for breast and ovarian cancer. Less known is the fact that men with these mutations also are at risk of breast cancer and other cancers.Astudy published in April in JAMA Oncology finds that few men are screened for these genetic mutations — and the researchers strongly suggest that they be sc...
Source: UCLA Newsroom: Health Sciences - May 31, 2018 Category: Universities & Medical Training Source Type: news

Brazilian woman born without vagina has one made out of fish skin
Jucilene Marinho, 23, from  Brazil, underwent a neovaginoplasty in April last year after being born with Mayer-Rokitansky-Küster-Hause left her with no cervix, uterus or ovaries. (Source: the Mail online | Health)
Source: the Mail online | Health - May 31, 2018 Category: Consumer Health News Source Type: news

Woman killed herself after surgeon removed ovaries without consent
The doctor said her ovaries were "in the way" (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 30, 2018 Category: Consumer Health News Source Type: news

South Carolina J & J Baby Powder-Mesothelioma Case Ends in Mistrial
A South Carolina judge declared a mistrial Friday in a high-stakes case blaming asbestos-contaminated Johnson & Johnson Baby Powder for a woman’s mesothelioma. Jurors failed to reach a unanimous decision in the case of Bertila Boyd-Bostic, who was diagnosed with pericardial mesothelioma at the age of 30 and died 15 months later. Bostic’s husband, Antoine Bostic, sued Johnson & Johnson, talc supplier Imerys Talc America and drug store chain Rite Aid, alleging his wife’s death was caused by years of asbestos exposure from inhaling J&J baby powder. The 12-member jury could only reach a unanimous ...
Source: Asbestos and Mesothelioma News - May 29, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Ovarian cancer rates plummet as more take contraceptives
A new report from the American Cancer Society has revealed the latest statistics on ovarian cancer for 2018, showing a decline in mortality rates as well as incidence rates. (Source: the Mail online | Health)
Source: the Mail online | Health - May 29, 2018 Category: Consumer Health News Source Type: news

Clovis gets European regulatory OK for its ovarian cancer drug
Clovis Oncology Inc. said it's received approval from the European Commission for its drug to treat recurrent ovarian cancer in women. The Boulder biotech (Nasdaq: CLVS) said the European regulators okayed its Rubraca (rucaparib) drug treatment for women with BRCA mutated ovarian cancer. The company, and its CEO Patrick Mahaffy, were profiled by the Denver Business Journal's Greg Avery last month, including the company's plans f or the drug in the U.S. "The granting of the (European) license means… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 29, 2018 Category: Health Management Authors: Ben Miller Source Type: news

Clovis gets European regulatory OK for its ovarian cancer drug
Clovis Oncology Inc. said it's received approval from the European Commission for its drug to treat recurrent ovarian cancer in women. The Boulder biotech (Nasdaq: CLVS) said the European regulators okayed its Rubraca (rucaparib) drug treatment for women with BRCA mutated ovarian cancer. The company, and its CEO Patrick Mahaffy, were profiled by the Denver Business Journal's Greg Avery last month, including the company's plans f or the drug in the U.S. "The granting of the (European) license means… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 29, 2018 Category: Biotechnology Authors: Ben Miller Source Type: news

Woman killed herself after ovaries removed without consent
Lucinda Methuen-Campbell had been in pain for years but it got worse after a bowel operation. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 29, 2018 Category: Consumer Health News Source Type: news